Here, we report that DOX therapy induced increased circulating levels of the neutrophil markers PGLYRP1, CAMP, MMP9, and CEACAM8 early after a single dose of chemotherapy in breast cancer patients. This evidence concerns the gene CEACAM8 and breast carcinoma.